OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings
 

About: Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.

Employees: 37

Healthcare Drug Manufacturers - General

Financial journalist opinion

Neutral
Newsfile Corp
4 months ago
EdgeTI Appoints Mel Wesley to its Industry Advisory Council and Subsequently Appoints Brian Groody as Director
Arlington, Virginia--(Newsfile Corp. - January 10, 2025) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5i) ("edgeTI", "Company"), a leading provider of real-time Digital Twin software, announces that it has appointed Mel Wesley to its Industry Advisory Council ("IAC") following his resignation as a Director on January 7, 2025. Following Mr.
EdgeTI Appoints Mel Wesley to its Industry Advisory Council and Subsequently Appoints Brian Groody as Director
See News Rankings
Charts implemented using Lightweight Charts™